ADVERTISEMENT

Buy, Sell Or Hold: Titan, TCS, Canara Bank, Zomato, IRFC, Container Corp — Ask Profit

Analysts also shared insights on the share prices of GlaxoSmithKline Pharmaceuticals and Samvardhana Motherson International.

<div class="paragraphs"><p>Analysts shared insights on the share prices of Tata Consultancy Services (TCS), GlaxoSmithKline Pharmaceuticals, Titan, Zomato, Indian Railway Finance (IRFC), Canara Bank, Samvardhana Motherson International and Container Corp (Photo: Envato)</p></div>
Analysts shared insights on the share prices of Tata Consultancy Services (TCS), GlaxoSmithKline Pharmaceuticals, Titan, Zomato, Indian Railway Finance (IRFC), Canara Bank, Samvardhana Motherson International and Container Corp (Photo: Envato)

Should you buy shares of Titan Co. and Samvardhana Motherson International Ltd. at the current market price? Is Container Corp. a good choice from a long-term perspective? Should you keep holding shares of Zomato Ltd. and Canara Bank?

Ravi Singh, senior vice president of retail research at Religare Broking, and Mahesh Ojha, research analyst at Hensex Securities Pvt, answered these investor queries and more on NDTV Profit's Ask Profit show.

Titan (CMP: Rs 3,048.50)

Singh: Buy

  • Buy and accumulate shares of Titan, with a stop loss at Rs 2,800.

  • Positive returns expected in upcoming months.

Opinion
Trade Setup For March 5: Multiple Support Zones Near 21,800

Zomato (CMP: Rs 227.61)

Singh: Hold

  • Average the stock at Rs 210 to Rs 220 level.

  • Stock is expected to hit Rs 285 to Rs 290.

Opinion
Zomato, Swiggy At Discount — Food Delivery Being Ignored Versus Quick Commerce, Says ICICI Securities

Container Corp (CMP: Rs 628.40)

Singh: Sell

  • Wait till a stop loss of Rs 570, and average at the Rs 610 level.

  • Bullish on IRFC and RVNL in this space.

Opinion
Container Corp Q3 Results: Profit Up 11%, Dividend Of Rs 4.25 Per Share

Tata Consultancy Services (CMP: Rs 3,532.05)

Ojha: Buy

  • Levels are good even with negative aspects factored in.

  • Any downside could be a good buying opportunity.

Opinion
IT Giants Infosys, TCS To See 7-9% Growth in FY26: Dolat Capital’s Rahul Jain

GlaxoSmithKline Pharmaceuticals (CMP: Rs 2,647.55)

Singh: Hold

  • Structure of the stock is good, with strong fundamental capacity.

  • Has potential to breach Rs 3,200 level.

Ojha: Buy

  • Stock possesses good upside potential.

  • Optimistic for Rs 2,950 to Rs 3,000 level in the next three to six months.

Opinion
GSK Pharma Q3 Results: Profit Increases Fivefold, Beats Estimates

Samvardhana Motherson (CMP: Rs 119.41)

Singh: Sell

  • Right time to book profits as stock is expected to undergo major correction.

Indian Railway Finance Corp (CMP: Rs 114.59)

Singh: Buy

  • IRFC is near its long-term support, and consolidating at attractive levels.

  • Enter at current market levels.

Opinion
IRCTC, IRFC Receive 'Navratna' Status

Canara Bank (CMP: Rs 81.94)

Singh: Buy

  • Enter at Rs 75 level.

  • Stock is expected to hit target to Rs 120 in the next eight to nine months.

Ojha: Hold

  • Stock has much more potential for upside, especially with a subsidiary expected to list.

  • Expect Rs 94 to Rs 95 level in the near-term.

Opinion
Canara Bank Conservative On Growth; Cuts FY26 Credit, NIM Guidance
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit